Zhu L - Search Results

1

A recombinant IL-1β vaccine attenuates bleomycin-induced pulmonary fibrosis in mice.

Li H, Li Q, Hao Z, Zhang L, Zheng X, Zhu L, Huo Y, Tian H, He L, Hao Z. Li H, et al. Among authors: zhu l. Vaccine. 2024 Jul 11;42(18):3774-3788. doi: 10.1016/j.vaccine.2024.04.091. Epub 2024 May 6. Vaccine. 2024. PMID: 38714443

2

Altered frequencies of memory B cells in new-onset systemic lupus erythematosus patients.

Zhu L, Yin Z, Ju B, Zhang J, Wang Y, Lv X, Hao Z, He L. Zhu L, et al. Clin Rheumatol. 2018 Jan;37(1):205-212. doi: 10.1007/s10067-017-3877-1. Epub 2017 Oct 25. Clin Rheumatol. 2018. PMID: 29067587

3

Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus.

Zhu L, Zhang J, Wang J, Lv X, Pu D, Wang Y, Men Q, He L. Zhu L, et al. Lupus. 2021 Jun;30(7):1116-1123. doi: 10.1177/09612033211005067. Epub 2021 Apr 8. Lupus. 2021. PMID: 33832361

4

Alterations of peripheral blood B cell subsets in Chinese patients with adult idiopathic inflammatory myopathies.

Wang Y, Zhu L, Ju B, Luo J, Li Q, Lv X, Pu D, Hao Z, Wang J, He L. Wang Y, et al. Among authors: zhu l. Clin Exp Rheumatol. 2022 Feb;40(2):260-266. doi: 10.55563/clinexprheumatol/ohsmuj. Epub 2021 Dec 10. Clin Exp Rheumatol. 2022. PMID: 34905483 Free article.

5

Immunomodulatory effect and safety of TNF-α RNAi mediated by oral yeast microcapsules in rheumatoid arthritis therapy.

Hu N, Zhu L, Zhang L, Wang J, Wang Y, Luo J, He L, Hao Z, Zhang L. Hu N, et al. Among authors: zhu l. Mater Today Bio. 2022 Aug 7;16:100384. doi: 10.1016/j.mtbio.2022.100384. eCollection 2022 Dec. Mater Today Bio. 2022. PMID: 35991628 Free PMC article.

6

The proportion and phenotypic changes of CD4⁺CD25^-Foxp3⁺ T cells in patients with untreated rheumatoid arthritis.

Ju B, Zhu L, Wang J, Zheng J, Hao Z, Luo J, Zhang J, Hu N, An Q, Feng X, Huo Y, He L. Ju B, et al. Among authors: zhu l. BMC Immunol. 2022 Sep 6;23(1):41. doi: 10.1186/s12865-022-00517-0. BMC Immunol. 2022. PMID: 36064312 Free PMC article.

7

Peripheral immunophenotypes associated with the flare in the systemic lupus erythematosus patients with low disease activity state.

Zheng J, Zhu L, Ju B, Zhang J, Luo J, Wang Y, Lv X, Pu D, He L, Wang J. Zheng J, et al. Among authors: zhu l. Clin Immunol. 2022 Dec;245:109166. doi: 10.1016/j.clim.2022.109166. Epub 2022 Oct 19. Clin Immunol. 2022. PMID: 36270468

8

The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients.

Wang J, Ju B, Zhu L, Li H, Luo J, Zhang J, Hu N, Mo L, Wang Y, Pan Y, Huang J, Lv X, Pu D, Hao Z, He L, Li Y. Wang J, et al. Among authors: zhu l. Front Pharmacol. 2023 Feb 16;14:1080730. doi: 10.3389/fphar.2023.1080730. eCollection 2023. Front Pharmacol. 2023. PMID: 36873989 Free PMC article.

9

Growth Differentiation Factor 11 Evokes Lung Injury, Inflammation, and Fibrosis in Mice through the Activin A Receptor Type II-Like Kinase, 53kDa-Smad2/3 Signaling Pathway.

Li Q, Li H, Zhu L, Zhang L, Zheng X, Hao Z. Li Q, et al. Among authors: zhu l. Am J Pathol. 2024 Nov;194(11):2036-2058. doi: 10.1016/j.ajpath.2024.07.016. Epub 2024 Aug 13. Am J Pathol. 2024. PMID: 39147236

10

Type I interferon-stimulated genes predict clinical response to belimumab in systemic lupus erythematosus.

Li H, Ju B, Luo J, Zhu L, Zhang J, Hu N, Mo L, Wang Y, Tian J, Li Q, Du X, Liu X, He L. Li H, et al. Among authors: zhu l. Eur J Pharmacol. 2025 Jan 15;987:177204. doi: 10.1016/j.ejphar.2024.177204. Epub 2024 Dec 11. Eur J Pharmacol. 2025. PMID: 39672224

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,969 results

Search Page

Filters